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Abstract
Airway mucin secretion studies have focused on goblet cell responses to exogenous ago-
nists almost to the exclusion of baseline mucin secretion (BLMS). In human bronchial epi-
thelial cell cultures (HBECCs), maximal agonist-stimulated secretion exceeds baseline by
~3-fold as measured over hour-long periods, but mucin stores are discharged completely
and require 24 h for full restoration. Hence, over 24 h, total baseline exceeds agonist-in-
duced secretion by several-fold. Studies with HBECCs and mouse tracheas showed that
BLMS is highly sensitive to mechanical stresses. Harvesting three consecutive 1 h baseline
luminal incubations with HBECCs yielded equal rates of BLMS; however, lengthening the
middle period to 72 h decreased the respective rate significantly, suggesting a stimulation
of BLMS by the gentle washes of HBECC luminal surfaces. BLMS declined exponentially
after washing HBECCs (t1/2 = 2.75 h), to rates approaching zero. HBECCs exposed to low
perfusion rates exhibited spike-like increases in BLMS when flow was jumped 5-fold: BLMS
increased >4 fold, then decreased within 5 min to a stable plateau at 1.5–2-fold over control.
Higher flow jumps induced proportionally higher BLMS increases. Inducing mucous hyper-
plasia in HBECCs increased mucin production, BLMS and agonist-induced secretion.
Mouse tracheal BLMS was ~6-fold higher during perfusion, than when flow was stopped.
Munc13-2 null mouse tracheas, with their defect of accumulated cellular mucins, exhibited
similar BLMS asWT, contrary to predictions of lower values. Graded mucous metaplasia in-
duced in WT and Munc13-2 null tracheas with IL-13, caused proportional increases in
BLMS, suggesting that naïve Munc13-2 mouse BLMS is elevated by increased mucin
stores. We conclude that BLMS is, [i] a major component of mucin secretion in the lung, [ii]
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sustained by the mechanical activity of a dynamic lung, [iii] proportional to levels of mucin
stores, and [iv] regulated differentially from agonist-induced mucin secretion.
Introduction
Mucus in the airways represents the first line of innate defense in the airways against inhaled
aerosols and pathogens [1]. In healthy lungs it is formed on the airway mucosa from the secre-
tion and hydration of mucins from surface goblet cells (MUC5AC and MUC5B) and from sub-
mucosal glands (MUC5B alone). In all the inflammatory lung diseases (chronic bronchitis,
asthma, cystic fibrosis, etc.), however, mucous metaplasia, hyperplasia, and hypertrophy drive
mucin hypersecretion which often results in mucous plugging of the airways and other patho-
logical conditions [2]. Because of this clinical duality, mucus and the secretion of mucins have
been major areas of interest in lung biology over the last 50 or more years, increasingly so in
the past decade.
In contrast to submucosal glands, where secretion appears to be regulated primarily by sym-
pathetic and parasympathetic innervation [3,4], airway goblet cells are regulated locally by
paracrine and autocrine mediators, especially ATP [5,6]. Notably, the focus of research on gob-
let cell mucin secretion has been on agonist-induced mucin secretion, to the virtual exclusion
of consideration of mucin secretion at baseline. Retrospectively, this focus may have been
short-sighted: in 11 studies from 6 different laboratories working with goblet cells in native air-
ways or primary airway epithelial cell cultures from human and other mammalian sources [7–
16], the average increase of ATP-induced mucin release was just 3.2 ± 0.5 fold higher than
baseline when determined over equal periods of time (mean ± SE). This modest stimulation
suggests a hypothesis that the mucins secreted at baseline may be significant, a prospect investi-
gated in this paper.
The terms, baseline, basal, and constitutive secretion can all be used to indicate the release of
material under control conditions, but they are also used in different contexts by physiologists
and cell biologists. Since constitutive secretion and basal (= ‘constitutive-like’) secretion relate
directly to different limbs of the secretory pathway [5,17] we use the term, baseline secretion, to
describe the release of mucins in the absence of exogenously applied agonist. It is used without
regard to a specific limb of the secretory pathway, or mechanism; however, the release of mu-
cins is presumed to occur exclusively via the regulated secretory pathway, and not via the con-
stitutive pathway, as evidenced by its dependency on extracellular signals, cytoplasmic Ca2+,
and the second messenger sensing, SNARE-priming protein Munc13-2.
In mouse, the deletion of Munc13-2 resulted in a loss-of-function phenotype in the airways
that was interpreted as a defect in the secretory pathway [7]. The phenotype signified the po-
tential importance of baseline mucin secretion. The secretory cells of mouse airways, club cells
(formerly Clara cells), do not stain with alcian blue/periodic acid-Schiff (AB/PAS) under con-
trol conditions, due to a paucity of stored mucins. Club cells assume a goblet cell-like pheno-
type in inflammation [18], and are converted to a goblet cell-like model for experimental
purposes by upregulating mucin production with the induction of allergic mucous metaplasia
[19,20]. In the Munc13-2 null mouse under control conditions, however, the club cells are posi-
tive for AB/PAS (AB/PAS+) which was shown to be due to an accumulation of mucin secretory
granules in the absence of increased mucin production. Deletion of the Munc13-2 gene inter-
fered with baseline mucin release, causing an accumulation in mucin stores [7]. Previously,
club cells were thought to be devoid of mucin under control conditions, but this study showed
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that mucins are in fact produced in WTmice. Rather than being stored in significant quanti-
ties, though, the mucins are secreted at baseline.
In this paper, human bronchial epithelial cell cultures (HBECCs; see Abbreviations and def-
initions, S1 File) and mouse tracheas were used to test the significance of goblet cell baseline
mucin secretion in the airways and to identify potential physical and humoral factors that
might modulate or regulate baseline release. The data derived suggest that baseline mucin se-
cretion is the predominant mode of goblet cell mucin release in the healthy lung, and is likely
to also contribute significantly, if not predominately, to mucus and/or sputum formation in al-
lergic and infectious inflammation.
Methods
Materials
ATPγS was purchased from Roche Applied Science (Indianapolis, IN); unless otherwise noted,
all other chemicals were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO).
Mouse care and experimental procedures
Munc13-2 (C57BL/6 background) and P2Y2R (129S6 background) deficient mice were re-
ceived originally from Drs. Niels Brose (Max Planck Institute of Experimental Medicine, Ger-
many; [21] and Beverly Koller [University of North Carolina, Chapel Hill, NC; [22]). The
respective 129S6 WTmice were purchased from Taconic (Hudson, NY), or The Jackson Labo-
ratory (Bar Harbor, ME), respectively. All mice were bred and raised at the University of North
Carolina and allowed food and water ad libitum. Some animals were treated with ovalbumin
(OVA) or IL-13 instillation under isoflurane anesthesia as described below; all animals were ul-
timately euthanized with gaseous CO2 prior to tissue harvest by dissection. All experimental
procedures using mice were conducted under protocols approved by the University of North
Carolina Institutional Animal Use and Care Committee.
Airway mucous metaplasia
Airway mucous metaplasia was induced in mice using the OVA sensitization and challenge
procedure detailed previously [11]. Briefly, OVA was injected i.p. on days 0, 7 and 14, and on
days 21 and 24, 50 μl of 2.0% OVA in PBS was instilled by aspiration into tracheas of isoflur-
ane-anaesthetized mice. Experimental procedures were performed 3–5 days following the 2nd
OVA instillation. Alternately, using the same isoflurane anesthesia, mucous metaplasia was in-
duced instead by the direct instillation of IL-13 into the trachea (recombinant, carrier free mu-
rine IL-13, (Biolegend, San Diego, CA). To achieve a variable degree of IL-13-induced
metaplasia, the number of instillations and the time between the last instillation and tissue har-
vest were varied, as described in Results and in Table 1.
Mouse tracheal perfusion and mucin ELISA
Tracheas harvested following CO2 euthanasia were canulated at their proximal ends and per-
fused at ~30 μl/min with warmed, 5% CO2/95% O2-equilibrated DMEM/F12 as detailed previ-
ously [11]. The entire set-up (pump, solutions, tissues, fraction collector) was housed in a
humidified Nuaire DH Autoflow CO2 incubator (Plymouth, MN, USA), factory customized to
lie horizontally. Mucins were collected into the wells of 96-well, non-binding, polystyrene mi-
crotiter storage plates (# 3594, Corning, Tewksbury, MA). Following an experiment, the plates
were tightly sealed and frozen until assessed for mucins in the collected fractions using an
ELISA.
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The ELISA followed the procedures developed in this laboratory and described in a recent
methods paper [23]. It used a mucin subunit antibody, a polyclonal antibody that recognizes
all vertebrate polymeric mucins [11,23,24] (the antibody was a gift of Dr. David Thornton).
Standard curves were generated from mucins purified from sputum collected from patients
with cystic fibrosis [23] applied to each plate and analyzed by fitting with the Four Parameter
Logistic Equation using a data acquisition and analysis software package, SoftMax Pro, that ac-
companied the SectraMax Plus plate reader (Molecular Devices, Sunnyvale, CA). The results
were expressed as the equivalent nanogram of mucin released per each fraction for each tra-
chea. Data generated from this assay are identified in figure legends as having been derived
with the ‘subunit ELISA’. Assay sensitivity for these tracheal perfusions was increased by mini-
mizing assay-to-assay variability, by assessing all the samples for an experiment at the same
time. Potential statistical differences between sample means in these experiments were sub-
jected to a Student’s t test, assuming equal variances, with statistical significance being indicat-
ed at p<0.05.
Histology and microscopy
Human and mouse tissues were fixed in formalin, dehydrated and embedded in paraffin, and
sections cut at 5 μm were placed on slides, deparaffinized, rehydrated, and stained with AB/
PAS, using a 5 min incubation in 0.5% periodic acid, following standard protocols. Where nec-
essary, mucous metaplasia in mouse lungs was quantified from images of the left interlobar
bronchus taken with an upright Nikon Microphot-SA microscope interfaced with a DXM 1200
color camera (Nikon Instruments) at 10X magnification. The AB/PAS-positive area was deter-
mined using ImageJ image processing software (http://rsb.info.nih.gov/ij/) to threshold gray-
scale images, expressing the integrated density of the area of AB/PAS+ mucosubstances per
unit length of basement membrane [25,26].
Human bronchial epithelial cell culture, mucin biochemistry, and mucin
secretion
HBE cells were obtained in accordance with Institutional Review Board-approved protocols, as
described previously [23,27], from normal human bronchi. Briefly, HBE cells were isolated and
grown on plastic culture dishes in bronchial epithelial cell growth medium and passaged at
80% confluence, and first-passage cells were seeded onto 12-mm Transwell-Clear supports
(TClears; Corning) at 250,000 per support. At confluence, the cells were maintained under air-
liquid interface (ALI) conditions in ALI culture medium (bronchial epithelial cell growth medi-
um modified per Ref [27]), which was changed at the basolateral surface three times a week.
Table 1. IL-13 Treatments Used to Induce Graded MucousMetaplasia.
IL-13 Treatment Day of Experiment Degree of Metaplasia Mucus Plugs
# 0(control) Day 0; 0 μg IL-13 Day 3 - -
# 1 Day 0; 1 μg Day 3 + -
# 2 Day 0, 1; 2 μg each Day 2 ++ -
# 3 Day 0, 1, 2; 1 μg each Day 3 +++ +
# 4 Day 0, 1, 2; 1 μg each Day 5 ++++ +++
Responses:— = no effect, + = visible increase, ++ = substantial increase, +++ = major increase, ++++ = extraordinary increase.
doi:10.1371/journal.pone.0127267.t001
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HBECCs were used for experiments 4–6 weeks post-confluence, a time when the columnar
cells are well differentiated as ciliated and goblet cells.
MUC5B in HBECCs was analyzed by Western blotting following extraction with 300 μl of
the extraction buffer in the RNeasy Mini Kit (Cat. #74104, Qiagen). Since this is a guanidine-
based buffer, it serves equally well for the extraction of nucleic acids and mucins from HBECCs
[28,29]. The sample extracts were prepared for electrophoresis on 1% agarose gels as previously
described [30,31]. After electrophoretic separation and vacuum blotting of the mucins onto ni-
trocellulose, the mature and immature forms of MUC5B in the immunoblots were probed
semi-quantitatively with the following specific antibodies:
MUC5B—immature peptide, 5BVNTR-1, a rabbit polyclonal antibody generated for this
study that recognizes a sequence (SSPGTATALPALRSTATTPTATS) in the PTS/mucin tan-
dem repeat domains of MUC5B prior to glycosylation (restricting detection to MUC5B pep-
tides formed in the ER, before transit to the Golgi complex); and,
MUC5B—mature glycoprotein, EU-MUC5B, a mouse IgG1, (a gift from Dr. David Thorn-
ton, University of Manchester), that recognizes the peptide sequence, RNREQVGKFKMC, lo-
cated in the globular, Cys-rich subdomains within the PTS/mucin tandem repeat domains
[32].
Mucin secretion experiments with HBECCs under static, i.e., non-perfused, conditions were
conducted as detailed previously [23]. Briefly, the mucus which accumulates on the luminal
surfaces HBECCs in the 2–3 days between culture maintenance under ALI conditions was re-
moved with a ‘Careful Wash’, a series of 4 luminal washes rigorously controlled to minimize
mechanical vibration and shear forces associated with replacement of luminal liquid. Each
‘wash’ consisted of the addition of 0.5 ml DMEM/F12 culture medium warmed to 37°C and ei-
ther a 10 min (1st wash) or 60 min (washes 2–4) incubation. The liquids removed were saved
and the contained mucins determined along with the mucins later secreted during the experi-
ments (see Fig 1 and [23]). The cultures were then used in the experiments, as detailed in Re-
sults. Mucins in the luminal liquids removed from the cultures were assessed by ELISA using
the same mucin subunit’ antibody used for mouse tracheal samples (above), and, as above, data
generated from this assay are identified in figure legends as having been derived with the ‘sub-
unit ELISA’.
The high resolution video microscopy and mucin secretion data of Fig 6A were collected in
1993, following previously detailed procedures [33].
Perfusion of HBECCs and mucin ELLA
HBE cells were grown as above, on 24-mm TClears, beginning with a plating density of 1 mil-
lion per support. At the time of the experiments, the cultures were removed from the incubator
and the luminal surface was washed with a single volume of DMEM/F12 medium before being
fitted with a gasket made from 2 mm Neopreme material. The gasket had a 10 x 16 mm round-
ed-rectangular cutout that defined a perfusion slot (volume = 270 μl; see S1 Fig). Next, a perfu-
sion plug with an O-ring seal was inserted into the TClear (see [9]) which allowed perfusion of
the HBECC over a 2 mm high area defined by the gasket. The cultures were perfused at 100 μl/
min with DMEM/F12 medium using a Harvard Apparatus (Holliston, MA) PHD 2000 syringe
pump during a 2 h equilibration period, following which 1 min fractions were collected during
a 10 min baseline secretion period. The perfusion rate was then elevated in a single step to a
higher rate, as described in Results, with fractions continuing to be collected at 1 min intervals.
After the experiment, the mucins contained in the fractions were determined with an ELLA,
using wheat-germ agglutinin (WGA) to detect the mucins, as described previously [23]. Data
generated from this assay are identified in figure legends as having been derived with the
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‘WGA ELLA’. The shear stresses (τω) due to flow at the epithelial surface, expressed as milli-
dynes/cm2 (mdyn/cm2) were estimated from flow through a rectangular slot, consistent with
Poiseuille flow (for which the slip velocity at the cell surface was assumed to approximate to 0):
to ¼ 6ZQ=wh2 ;
where
η = viscosity, and is assumed equal to water, 0.001 Pa-s;
Q = volume flow rate, cm3/s; and,
w = width of the channel, 0.85 cm;
h = height of the channel, 0.19 cm.
Similarly, shear stresses imposed during the perfusion of mouse tracheas were calculated for
Poiseuille flow through a cylinder, as,
to ¼ 4ZQ=pr3;
where
r = radius, taken as a nominal 0.1 cm.
Fig 1. Mucin secretion from HBECCs. A.Measuredmucins.Mucins were assessed by subunit ELISA for
the accumulated mucus removed from HBECCs with a series of Careful Washes (Wash 1, 10 min, Wash
3–4, 1 h), and from the secretions released during 1 h baseline and agonist stimulation (100 μMATPγS)
periods. Data are expressed as the mean ± SE, n = 10 sets of HBECCs.B. Predictedmucin release.Mucin
release predicted for a 24 h day from the data in Panel A. Predicted baseline was estimated by extended the
1 h baseline out to 24 h. Agonist-induced secretion over 24 h was estimated as just that released acutely (see
text). Note the different scales, left and right.
doi:10.1371/journal.pone.0127267.g001
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Poiseuille flow was assumed based on Reynolds Numbers (Re = 4Qρ/ ηP, where ρ = density
and P = channel perimeter) for the flows used in our experiments (100 to 1,000 μl/min): Re
ranged from 0.48 to 4.80, well below the threshold of 2040 for turbulent flow.
Results
Baseline secretion from HBECCs
Baseline versus agonist-stimulated mucin secretion in HBECCs. As background, these
first studies began with a methodological effort to define a rigorous, but practical, wash proce-
dure for HBECCs that would minimize mechanical stress during removal of accumulated
mucus, while preserving goblet cell mucin stores [15,23]. This procedure now allows a compar-
ison of the relative amounts of mucin secreted at baseline and during agonist stimulation of
HBECCs (ATPγS, 100 μM) [5], as well as the mucins removed from the luminal surfaces dur-
ing preparatory wash periods (i.e., a ‘Careful Wash’). Fig 1A shows that the mucins released by
agonist, 1.1 ± 0.2 μg/culture, were 3.3-fold higher than baseline release, both measured over 1 h
periods, consistent with previous determinations [10,12,14–16]. Not only was the ratio of base-
line/stimulated mucin release modest, but the quantity of mucins removed from the cultures
prior to the experiment, 5.98 μg, exceeded those released in response to agonist by 5.7-fold.
These data are consistent with a relatively robust release of mucins at baseline; however, any
conclusion regarding the relative rates of baseline and agonist-induced mucin secretion over
macroscopic periods of time requires knowing the time required for intracellular mucin store
recharge following stimulation by agonist.
To determine the recovery time for mucin stores, HBECCs were washed free of accumulated
mucins, stimulated for 1 h with 100 μMATPγS, and cultures were then periodically fixed for
histology or extracted for total mucin determinations for up to 72 h post-discharge. Consistent
with the original observations of Kemp, et al [15], maximal stimulation with P2Y2 agonist
caused a full discharge of HBECC mucin stores, relative to control, as is apparent at t = 0 by the
paucity of AB/PAS staining and by the minimal staining of agarose Western blots stained for
the mature, glycosylated form of MUC5B (Fig 2A and 2B). The recovery of mucin stores was
followed semi-quantitatively by Western blotting (Fig 2B and 2C), staining for mature
MUC5B, as well as for the non-glycosylated MUC5B peptide. The latter is taken as an index of
mucin synthesis since this form of MUC5B occurs only in the ER [34]. From these data, it is
clear that several hours are required following a full mucin discharge for a significant recovery
of mucin stores: mucin synthesis appeared to peak as a broad plateau, 8–16 h post-discharge,
and the half-time of mucin store recovery was 8–12 h post-discharge (Fig 2C). Full recovery of
mucin stores required ~24 h.
With the time required for mucin store recharge established, the data in Fig 1A were used to
estimate the relative amounts of mucin secreted over the period of a day by baseline and ago-
nist-induced secretory modalities (Fig 1B). The mucins secreted over 24 h during agonist stim-
ulation were taken as those released during a 1 h exposure to ATPγS, since the treatment fully
exhausts mucins stores and a complete recovery takes the better part of a day (Fig 2). The mu-
cins secreted at baseline were estimated by projecting the 1 h rate of release out over 24 h, since
the release presumably reflects a steady-state activity of the goblet cells. When viewed this way
(Fig 1B), baseline mucin secretion is predicted to exceed agonist induced mucin secretion by
>7-fold over the course of a day. This, of course, is an overestimate because agonist-stimulated
goblet cells achieve a full recharge in less than 24 h, and are presumably capable of further ago-
nist-induced secretions. However, if one doubled the mucins secreted in response to agonist,
the amount would still be exceeded by mucins secreted at baseline each day by ~3.5 fold. The
calculation therefore suggests that the baseline release of mucins over the period of a day is
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potentially more substantial than a full, acute mucin release in response to agonist. Baseline
mucin release may therefore be an important, or predominant mucin secretory modality for
the healthy lung.
Sensitivity of baseline HBECCmucin secretion to experimental handling. Airway epi-
thelia are very sensitive to mechanical stresses, including the shear stresses associated with lu-
minal media changes and perfusion (e.g., see [35,36]). Consequently, we assessed the effects of
handling on HBECCs during experiments designed to measure baseline secretion, initially per-
forming two experiments similar to that in Fig 1. First, following a Careful Wash, the series of
washes preceding a baseline incubation period (see Fig 1), mucin release was determined dur-
ing 3 successive periods of equal, 1 h incubations, and again in the presence of agonist (ATPγS,
100 μM). The result (Fig 3A) showed that mucin secretion in all three periods of baseline secre-
tion were similar to one another, and the agonist-stimulated release was ~3-fold higher, as it is
when preceded with a single baseline period (c.f., Figs 1A and 3A).
Fig 2. Recovery of mucin stores in HBE cell cultures following agonist (ATPγS, 100 μM) induced discharge. A.HBECCs examined by AB/PAS
histology. HBECCs were fixed before (control) and periodically after exposure to agonist, and mucin stores were revealed by AB/PAS staining.B. Sample
agaroseWestern blots.Whole cell extracts of HBECCs sampled at the indicated times were subjected to electrophoresis in agarose gels, vacuum blotted,
and the blots probed for MUC5B with domain-specific antibodies. ‘Immature’, non-glycosylated mucin peptides were detected with an antibody to the PTS/
mucin repeat domains, and ‘mature’, fully glycosylated mucins with antibodies to the Cys-rich domains within the glycosylated mucin domains.C. Time
course of MUC5B peptides andmaturemucins.Mucin quantitation was achieved by densitometry of agaroseWestern blots as in Panel B; all results are
expressed relative to their respective controls. Left axis = MUC5B peptide as the immature, non-glycosylated form of the mucin, right axis = mature MUC5B
glycoprotein. Time 0 = 45 min post-ATPγS, after cultures were washed to remove the secreted mucus; Controls (‘C’ in Panel B) = non-treated HBE cells.
Data expressed as the mean ± SE (n = 7–9 sets).
doi:10.1371/journal.pone.0127267.g002
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Second, the protocol above was followed with the exception that the second baseline period
was 72 h in duration (Fig 3B). Because HBECCs cannot tolerate 0.5 ml of luminal medium for
more than 6–8 h during experiments such as these (the liquid becomes acidic and the epitheli-
um loses its integrity), luminal liquid was not added following harvest of the liquid for the first
baseline period. Instead the cultures were returned to the air:liquid conditions of the incubator.
After 71 h, 0.5 ml of media was added to the cultures and harvested 1 h later for the second
baseline period, with the experiment then being completed following normal procedures. In
this case, the rate of baseline mucin secretion (μg/h) during the second period was depressed
significantly relative to control (period B1, Fig 3B). In absolute terms, more mucins were
Fig 3. Measured baseline secretion rates vary with period duration. Following the Careful Wash protocol
of Fig 1, HBECCmucin secretion rates were determined for three successive baseline periods, then the
cultures were exposed to agonist (100 μMATPγS). A.Uniform baseline periods. The baseline periods were
all 1 hr in duration.B.Non-uniform baseline periods. The first and last baseline periods were 1 hr, but the
middle one was 72 hr in duration. After the cultures were sampled for the B1 period, they were returned to the
incubator for the 72 hr B2 period, and the mucins released were harvested by performing a 2nd Careful Wash
and combining the samples. n = 6; * p < 0.05 relative to period B1. Mucins in all samples were determined by
subunit ELISA.
doi:10.1371/journal.pone.0127267.g003
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released in the middle, 72 h period, but the larger amount was released over a much longer pe-
riod of time. Mucin release during the third baseline period rebounded and had a rate similar
to the control period, and agonist elicited its usual ~3-fold stimulation (Fig 3B).
The results above suggested that HBECCs are sensitive to the handling necessary to add and
remove luminal media, including the mechanical stresses associated with transferring the cul-
tures between incubator and tissue culture hood. To test this sensitivity more rigorously, the
time course of the potential relaxation in baseline mucin secretion was determined under con-
ditions in which handling of the cultures was minimized. Four sets of HBECCs, 7 cultures/set,
were Carefully Washed and returned to the incubator under luminal air:liquid conditions. Be-
ginning 1 h later, the first culture of each set was removed from the incubator, 0.5 ml of media
was added to the lumen, incubated 10 min, and removed for assessment of mucins released
during the intervening period. The other cultures in a set were treated similarly at 2–72 h, with
the mucins collected from each culture at just a single time point. As shown in the inset to Fig
4, mucins accumulated on the luminal surfaces of the HBECCs for the first few hours following
the wash, but then approached an apparent plateau. When plotted as a rate, baseline mucin se-
cretion decreased dramatically following a wash, reaching a stable minimum after 24 h; the
half-time of the relaxation was 2.75 h (Fig 4). Consequently, the appearance of a stable baseline
rate of secretion for the series of uniform 1 h sample periods shown in Fig 3A most likely re-
sulted from the periodic handling of the cultures necessary to harvest the mucins at the end of
each period. Also, washing a HBECC in a standardized manner appears to induce a unitized re-
sponse (Fig 3A and 3B).
Mucin secretion from perfused HBECCs. The results of the previous experiments sug-
gested that HBECCs are very sensitive to the mechanical stresses associated with handling and
pipetting. To assess the mechanical forces required to induce an elevation of mucin secretion at
baseline, we determined the sensitivity of mucin secretion from perfused HBECCs to changes
in perfusion flow rate. The lumens of HBECCs grown on large, 25 mm diameter TClear sup-
ports were perfused at a constant 100 μl/min flow rate for a 2 h equilibration period (S1 Fig),
and 1 min fractions then collected for a 10 min baseline period. A flow rate of 100 μl/min, cor-
responding to a shear stress of 3.35 mdyn/cm2, was selected as the initial perfusion rate, as pre-
liminary experiments indicated minimal effects of the associated with flows of this magnitude.
By comparison, this level of shear stress is on the order of 100-fold less than that associated
with airflow during tidal breathing, estimated at ~450 mdyn/cm2 [37], but it is in the middle of
the range known to stimulate the release of ATP in HBECCs [38,39]. After collection of the
fractions representing the baseline flow rate, the HBECC perfusion rate was then elevated, or
jumped, in a single step. As an example, Fig 5A shows the mucin secretory response to a sud-
den increase in flow rate from 100 to 500 μl/min (3.35 to 16.79 mdyn/cm2). Mucin secretion in-
creased>4-fold coincident with the increase in flow and then declined to a plateau level
elevated with respect to the baseline rate of release, despite the higher flow rate.
Fig 5B depicts the results from experiments in which perfusion flow rates were increased
over a range of 2.5 to 10-fold over the baseline flow of 100 μl/min, showing the peak and inte-
grated portions of the secretory responses observed. Interestingly, there is a linear relationship
for both the peak and integrated portions of the mucin secretory responses observed and the
increase in flow rate. Preliminary results examining increases less than 2.5-fold elicited weak,
uncertain mucin secretory responses, while those greater than 10-fold elicited high, but erratic
responses. The results suggest that mucin secretion from human airway epithelial cells is very
sensitive to the stresses associated with fluid flow, stresses that are well below the range estimat-
ed for the airways during tidal breathing [37], but within the range that stimulate ATP release
[38,39].
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Time course of agonist-stimulated mucin secretion from HBECCs. Following stimula-
tion of goblet cells by agonist, mucin granule exocytosis as determined directly by microscopy
occurs with a burst of exocytic events (EE) that lasts< 1 min, followed by a plateau lasting a
few minutes [33,40], essentially until the cell exhausts its granule stores (Fig 2A). When ago-
nist-stimulated mucin secretion is determined in perfused preparations using biochemical as-
says, however, the secretory response appears to last for ~20 min or more [10,33]. Fig 6A
illustrates this discrepancy with data derived, circa 1993, from a single nasal epithelial explant
in which an individual goblet cell was observed by microscopy while mucins secreted from the
entire explant were collected and analyzed by ELISA (per [33]). At the single-cell level the exo-
cytic response was brief, while mucins were collected in significant quantities for 10–
20 minutes.
To test whether the apparent discrepancy between the patterns of exocytosis and mucin re-
lease in Fig 6A was due to the secreted mucins being delayed in their exit by interactions with
Fig 4. Time course of changes in HBECC baseline mucin secretion following a Careful Wash. HBECCs were Carefully Washed and returned to the
incubator under air:liquid luminal conditions. The cultures were then removed as a function of time and luminal mucus harvested with minimal perturbation.
Cultures were sampled just once; different sets of cultures were used at the different time points (n = 4). Inset: Data plotted to show the total mucins harvested
from the cultures over time. Mucins in all samples were determined by subunit ELISA.
doi:10.1371/journal.pone.0127267.g004
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the walls of the perfusion chamber and tubing, a series of non-perfused HBECCs were stimu-
lated with ATPγS and the luminal liquid was collected at 5, 10, or 30 min. As shown in Fig 6B,
the quantity of mucins recovered after stimulation was independent of the time of collection,
indicating that the secretory response was effectively complete in< 5 min.
Mucin secretion and stores in HBECCs. If baseline mucin secretion is an important se-
cretory modality under control conditions, as the results above suggest, it is also important to
know whether or not it is increased during the mucous metaplasia, hyperplasia, and/or hyper-
trophy commonly associated with inflammatory conditions in the airways [2]. To test the po-
tential relationship in HBECCs between mucin stores and baseline secretion we compared the
output of mucins from cultures grown under control conditions with those in which inflamma-
tory mucous hyperplasia/hypertrophy was induced by a supernatant of mucopurulent material
(SMM; [41–43]), collected and prepared from lungs removed from patients with Cystic Fibro-
sis during organ transplant surgeries. SMM is a protein-rich, incompletely characterized
‘broth’ containing a multiple cytokines, nucleotides, and proteases that together induce a mas-
sive upregulation of mucin gene expression and mucous hyperplasia in HBECCs (e.g., see Fig 5
in Ref [42]). A 72 h treatment of HBECCs with SMM caused a massive upregulation of secreted
mucins (Fig 7). Visually, the surfaces of SMM-treated cultures appeared very ‘mucusy’, and the
total mucins contained in the accumulated mucus removed from the cultures before the mucin
secretion experiments was increased nearly 4-fold (Fig 7A). Consistent with the increase in
mucin secretion implied by this result, both the mucins secreted under static conditions at
baseline and in response to a maximal dose of ATPγS (100 μM) were also increased ~4-fold
(Fig 7B). The increased levels of HBECC intracellular mucin stores [42] appears to be associat-
ed with increased rate of secretion, at both baseline and in response to agonist (Fig 7).
Baseline secretion from mouse tracheas
The experiments with HBECCs above indicated that over macroscopic periods of time baseline
mucin release is the predominant modality of secretion, that it is very sensitive to physical
stresses, and that it may correlate with intracellular mucin stores. We used mouse models of
mucin secretion to extend these findings, beginning with the Munc13-2 null mouse in which
the accumulation of mucin in club cells under control conditions was hypothesized to be
caused by a defect in baseline secretion [7]. If true, a decreased baseline secretion in the null
mice might be expected; however, in our original studies, baseline mucin secretion rates ap-
peared to be no different in the tracheas of WT and Munc13-2 null animals [7]. Therefore, a
major goal of the present studies was to make a more definitive test of the hypothesis by mini-
mizing potential experimental artifacts (next paragraph) and maximizing sensitivity of the
mouse mucin detection assay (Methods, pages 4–5).
Perfusion effects in mouse tracheas. In the mouse tracheal perfusion protocol used in our
laboratory [11], tracheas are equilibrated for 2 h at the same, low perfusion rates used during
the experimental challenges (30 μl/min, ~51 mdyn/cm2). Mucin levels measured in the collect-
ed fractions begin at elevated levels and decline to a steady baseline rate of release over
Fig 5. Mucin secretory response of HBECCs to liquid shear stress.HBECCs were perfused luminally at 100 μl/min during 2 h equilibration and 10 min
baseline collection periods, then the perfusion rate was increased in a single step (arrow) by 2.5, 5, or 10 fold. Fractions collected during the baseline and
increased flow periods were assessed for secreted mucins by theWGA ELLA. A. Time course showing the effects of a 5-fold increase (jump) in flow
rate.Mucin secretion is plotted as mucin content/fraction, normalized to baseline (mean ± SE, n = 5). B. Relationship between themagnitude of the
change in flow rate, and the normalized peak and integratedmucin secretory responses. The normalized peak and 30 min, integrated mucin secretory
responses from the cultures subjected to different changes in flow-induced shear stress are plotted against the jump in flow rate. The abscissa shows the
final flow rates, fold jump in flow, and the calculated, final steady-state shear stresses at each final flow rate used. Each point represents the mean ± SE of 5
or more experiments.
doi:10.1371/journal.pone.0127267.g005
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approximately the first 45 min of the 120 min equilibration period (see Fig 5D in Ref [11]). To
test for effects of perfusion flow on measured baseline secretion, we adopted a stopped-flow
procedure: mouse tracheas were equilibrated with constant perfusion for 2 h as usual, following
which the perfusion was stopped for 30 min, then restarted and the perfusate collected into 5
Fig 6. Time course of agonist-inducedmucin secretion from human airways. A.Comparing
exocytosis (left axis) and secretions (right axis) in an individual perfused preparation. Analysis of the
secretory response of a single, luminally perfused human nasal epithelial explant, circa 1993, measuring
exocytic events in an individual goblet cell by microscopy, and mucin secretion from the same explant by
ELISA (see [33]; shear stress ~66 mdyn/cm2). The time course of mucin secretion was corrected for the
perfusion delay. Note the short duration of the exocytic burst, as measured by microscopy, and the relatively
prolonged time course of mucin secretion determined by the ELISA.B. Time course of mucin secretion
fromHBECCs (non-perfused). Following determination of mucin secretion during a baseline period (blue
bar; 30 min; n = 17), the mucins secreted in response to agonist (ATPγS, 100 μM) were determined by
subunit ELISA as a function of time (green bars; n = 3–5 cultures/time point). Individual cultures were used for
each time point. Note that the secretory response appears to be complete in the first 5 min.
doi:10.1371/journal.pone.0127267.g006
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min (~200 μl) fractions for an additional 35 min. Mucins released above the level of the per-
fused baseline during the period of reperfusion should reflect those secreted during the preced-
ing period of stopped-flow.
Fig 8A shows a progressive increase in AB/PAS+ staining of the club cells in the tracheal ep-
ithelium of Munc13-2 mice, with essentially no staining in +/+ mice and intermediate and
heavy staining in the Munc13-2 +/- and-/- mice, consistent with our original observations [7].
Fig 8B depicts the mucin secretion data for these mice, specifically, the mucins collected in
each fraction from perfused tracheas of WT and Munc13-2 mice following the 30 min period
of stopped-flow. Since data from the various Munc13-2 genotypes were similar and essentially
overlaid one another, the data were pooled to better estimate the baseline-perfused mucin re-
lease (red data points and line, Fig 8B; n = 15). Note that the levels of released mucins were ele-
vated in the first two fractions of reperfusion, and that for fractions 3–7 they lie on an obvious
plateau (dotted line in the figure). The value of plateau, 30.01 ± 1.14 ng mucin per 5 min frac-
tion, represents the average rate of baseline mucin release during perfusion for fractions 3–7.
For fractions 1 and 2, the mucins released at levels above the plateau (Fig 8B, gray area), were
taken to represent the mucins released during the preceding, 30 min period of stopped-flow.
When the data from the stopped-flow and perfused components of baseline mucin secretion
were so dissected and expressed as rates, baseline mucin release rates during perfusion ex-
ceeded the stopped-flow rates by ~4–6-fold (Fig 8C). Hence, restarting perfusion after a period
of stopped-flow stimulates baseline mucin release. Notably, the ~4–6-fold increase in mouse
tracheal mucin secretion caused by perfusion shear stresses is much larger than the effects of a
maximal dose of purinergic agonist (ATPγS) applied during constant perfusion, which is gen-
erally ~2 – 3-higher than the perfused baseline [11].
Since the mucin release data from the different Munc13-2 genotypes were similar (Fig 8B),
they could have been represented as single data set of stopped-flow and perfused baseline secre-
tion in Fig 8C. We chose to treat them separately, however, to emphasize the fact that there
Fig 7. Chronic effects of SMM (72 h) on HBECCs. A. Effects on total mucins. Total mucins removed during the Careful Wash, and during the baseline
and agonist-stimulated secretion periods, were determined individually, then summed.B. Effects on freshly secretedmucins.Mucins secreted at baseline
and in response to ATPγS (100 μM, 45 min; * p < 0.05, n = 5)). Note the different ordinate scales in A and B. Mucins in all samples were determined by
subunit ELISA.
doi:10.1371/journal.pone.0127267.g007
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Fig 8. Baselinemucin secretion fromMunc13-2 mouse tracheas. A. AB/PAS-stained sections of
intrapulmonary bronchus, illustrating the degree of intracellular mucin accumulation by genotype. B.
Mucins released during tracheal perfusion. Following a 30 min period of stopped-flow, perfusion was
restarted and 5 min (50 μl) fractions collected. Pooled data are indicated in red. Note the line labeled ‘mean,
perfused’, indicating the mean level of mucins released during Fractions 3–7: the area indicated in light gray,
above the line for Fractions 1 and 2, represents mucins released during stopped-flow. Mucins in all samples
were determined by subunit ELISA.C. Baselinemucin secretion during stopped-flow and perfusion.
Data from (B), expressed as a rate. Despite the greater quantities of mucin released during stopped-flow (B),
the corresponding rate of release is lower due to the longer duration of the 30 min period (vs. 5 min fractions
for the perfused period). Note the similarities in stopped-flow and perfused baseline secretion between
genotypes (NS; n = 5), despite the progressive increases in mucin stores in the Munc13-2 deficient mice (A).
doi:10.1371/journal.pone.0127267.g008
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were no differences in baseline mucin secretion in Munc13-2 deficient mice. These data are
consistent with previous measurements which also failed to detect differences in perfused base-
line mucin secretion levels in WT and Munc13-2 null mice [7]. Therefore, either our hypothe-
sis concerning a defect in baseline secretion in Munc13-2 null mice [7] is incorrect, or the
apparent lack of a difference indicates a compensating mechanism. A compensatory mecha-
nism that would tend to equate the baseline rates of secretion in the different Munc13-2 geno-
types would be a positive correlation of mucin secretion with the amount of mucin contained
in intracellular stores, a relationship that would also explain the increases in HBECC mucin se-
cretion during inflammation (Fig 7).
Mucin secretion vs. mucin stores: OVA-induced metaplasia. As an initial test of a possi-
ble relationship between mucin stores and secretion, we measured baseline mucin secretion
levels in WT mouse tracheas following induction of mucous metaplasia with ovalbumin. Rela-
tive to controls, OVA-induced mucous metaplasia increased mucin stores in club cells, as ex-
pected (Fig 9, top insets). Under stopped-flow conditions (Fig 9), OVA treatment caused a
4.0 ± 0.8 fold (n = 3) increase in baseline mucin secretion, relative to control, and under per-
fused conditions, baseline secretion was increased by 2.9 ± 0.7 fold (n = 3). Thus, the increased
levels of mucin stores caused by major stimulation with an inflammatory insult do appear to
correlate with higher baseline mucin secretion in mouse trachea, as they do in HBECCs (Figs 9
and 7).
IL-13-induced mucous metaplasia. To generate a mouse model with variable degrees of
allergic mucous metaplasia, AB/PAS staining was examined in a set of mice treated by tracheal
instillation with different amounts of IL-13, and/or for different times. Mice receiving 1 μg IL-
13 on 1, 2, or 3 consecutive days, or 2 μg IL-13 for 2 consecutive days, were examined for the
relative degree of mucous metaplasia on day 2, 3, or 5 (Table 1). Mucous metaplasia was deter-
mined by scoring both relative AB/PAS staining and degree of mucous plugging. Table 1 shows
that increasing the amount of IL-13 instilled, the number of instillations, and the amount of
time following the final instillation, all increased the degree of mucous metaplasia observed.
Notably, severe mucous plugging was observed in Treatment #4, in which mice received 3 con-
secutive IL-13 instillations and were examined on day 5, instead of day 3 (S2 Fig). From these
results, we chose to study mice for baseline secretion that received Treatments # 0 (control), 1,
and 3. Using these protocols, Fig 10A shows that a positive correlation between the rigor of the
IL-13 treatment and the degree of AB/PAS staining induced was achieved.
Tracheas harvested from the same mice studied in Fig 10A were perfused for baseline and
agonist-stimulated mucin secretion. As in the earlier studies, the tracheas were equilibrated
under continuous perfusion, perfusion was stopped for 30 min, restarted for 35 min, then the
perfusate was switched to one containing ATPγS (100 μM) for a final 30 min period and the
collected fractions were assessed for mucin content. Fig 10B shows the results as a series of scat-
ter-plots depicting mucin secretion versus AB/PAS staining under the different perfusion re-
gimes, with the control and increasingly rigorous IL-13 treatments indicated by different
symbols. Note the strong correlation between the degree of mucous metaplasia and measured
mucin release under each condition examined, i.e., baseline secretion, under both stopped-flow
and continuous perfusion, and agonist-stimulated conditions. These data, in aggregate, there-
fore indicate that mucin release under baseline conditions is sensitive to the stresses imposed
by perfusion flow, and that baseline and agonist-stimulated mucin secretion are both sensitive
to the amount of mucin contained in intracellular mucin stores. Additionally, the data support
the notion that the apparent lack of a mucin secretory phenotype in the Munc13-2 null mouse
(Fig 8) may be due to the elevated levels of mucin stores in the tracheas of the Munc13-2 null
mice that drive increased levels of mucin secretion, effectively masking the defect.
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Perfusion effects in mice deficient for P2Y2R. Substantial evidence accumulated over the
past two decades suggest that luminal purinergic signaling in the airways is responsible for
maintenance of the airway surface liquid and mucus transport. Central to the signaling sche-
mata proposed is the cellular release of ATP and its auto/paracrine feedback on the epithelium
through P2Y2 purinoceptors (P2Y2R; [39,44,45]). To test whether the effects of stresses associ-
ated with perfusion of mouse tracheas on mucin secretion were mediated by this signaling sys-
tem, we measured mucin secretion in tracheas from P2Y2R null mice, comparing them to WT
129S6 control mouse tracheas. As shown in Fig 11, there were no differences in baseline mucin
secretion in the WT and P2Y2R null mice under stopped-flow and perfused conditions within
the perfusion regime. Additionally, the increase in baseline mucin secretion when perfusion
was re-started was also similar in the WT and P2Y2R null mouse tracheas, a result suggesting
that perfusion effects on baseline mucin release are mediated by other, non-P2Y2 signaling
events. For clarity, these results do not exclude the possible involvement of ATP or other puri-
nergic agonists in the signaling events; they speak only against the involvement of the
P2Y2 purinoceptor.
Discussion
Agonist-induced versus baseline mucin secretion
A well-stained goblet cell in a histologic slide is impressive for the quantity of its stored mucins,
with the stores generally occupying the major fraction of the total cell volume (e.g., Figs 2, 9
Fig 9. Effects of ovalbumin-inducedmucousmetaplasia on baseline mucin secretion fromWTmouse
tracheas. Tracheas from control and OVA-treated were equilibrated under continuous perfusion, and
baseline mucin secretion was then determined under stopped-flow and following restoration of continuous
perfusion, per Fig 2, using the subunit ELISA (* p < 0.05, n = 3). Insets at the top compare AB/PAS staining in
sections of tracheas from control and OVA-treated mice.
doi:10.1371/journal.pone.0127267.g009
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and 10). Such observations sometimes lead to suggestions of goblet cells acting as sentinels,
holding mucin stores for acute release at a critical time in response to humoral or other cues.
This notion is reinforced by observations of living airway goblet cells in epithelial explants
from canine trachea and human nasal epithelia by differential interference contrast microsco-
py. For goblet cells at rest, the rates of mucin granule exocytosis are very low: in 75 cells
Fig 10. Effects of graded, IL-13 inducedmucousmetaplasia onWTmousemucin stores and
secretion. IL-13 (1 μg/instillation), or a sham, control solution, was instilled via the trachea into the airways of
anesthetized mice, following Treatment protocols 0 (—), 1 (+), and 3 (+++) in Table 1. At the appropriate
times following the last instillation, tracheas were harvested for mucin secretion experiments and the right
lung lobe of each mouse was fixed for histology. A. IL-13 Effects on AB/PAS staining in the airways.
Sections of the major intralobar bronchi were stained with AB/PAS and the degree of AB/PAS staining was
quantified using ImageJ. Note the progressive mucous metaplasia and in Treatment 3 (+++) the presence of
mucus plugs. The data are expressed as the integrated density per μm of basement membrane, using
Box Plots (25th, 50 th, 75 th percentiles). B. Relationship between AB/PAS staining andmucin secretion.
Following IL-13 treatment, excised mouse tracheas were mounted for perfusion and equilibrated for 2 h,
following which perfusion was stopped for the ‘Stopped-flow Baseline’, then restarted for the subsequent
‘Perfused Baseline’ and ‘Agonist Stimulated’ periods. The results are presented as scatter plots, with the
measured mucin secretion rates, determined from subunit ELISAs, plotted against the AB/PAS Integrated
Densities determined for the corresponding tissues from Panel A. Triangles, circles, and squares denote
control and the 2 different IL-13 treatments, as indicated by the code, upper-right. Empty symbols denote
secretions at baseline (stopped-flow and perfused) and filled symbols denote agonist-stimulated secretions.
For the agonist-stimulated, IL-13+++ data (solid green squares), note the high value point that appears with
the cluster of empty squares—to allow a simple visual comparison of the slopes, the scale for the agonist-
stimulated data was not expanded to separate the data. All 3 slopes were significant, with correlation
coefficients = 0.55, 0.61, and 0.59, and, with F ratio probabilities, p <0.005, <0.002, and <0.001.
doi:10.1371/journal.pone.0127267.g010
Fig 11. Persistence of perfusion effects in P2Y2R null mouse. After induction of mucous metaplasia with
IL-13, tracheas fromWT and P2Y2R null mice on the same 129S6 background were equilibrated under
continuous perfusion, and baseline mucin secretion was then determined under stopped-flow and following
restoration of continuous perfusion, from subunit ELISAs, per Fig 10 (* p < 0.05, n = 3 or 4).
doi:10.1371/journal.pone.0127267.g011
Baseline Goblet Cell Mucin Secretion
PLOS ONE | DOI:10.1371/journal.pone.0127267 May 29, 2015 20 / 27
observed for an aggregate period of 24.3 h, the average rate of exocytic events per cell was 0.05
EE/min [33,40]. These cells then responded to a maximal concentration of ATP (100 μM) with
a short,<1 min, burst of exocytoses with maximal rates of 87.9 (canine) and 118.2 (human)
EE/min, respectively, followed by a long-lasting plateau with much lower rates (1.9 EE/min in
canine trachea). In both studies, the goblet cells were totally, or nearly depleted in the first few
minutes of exposure to agonist [33,40], consistent with the observations in HBECCs that
mucin release is complete in<5 min (Fig 6), and that following release the goblet cells are fully
depleted of their mucin stores (Fig 2; [15]). In fact, the acute emptying of mucin stores is likely
of pathophysiologic importance in causing acute airway obstruction in patients suffering in-
flammatory airways diseases, and in concept it could lead to the formation of excessively con-
centrated mucus by overwhelming the ambient surface liquid. Such pathologies may occur, for
example, in patient airways with chronic bronchitis, status asthmaticus, and cystic fibrosis
[2,46].
Although the release of mucins under baseline conditions is not nearly as dramatic as the
acute exocytic response of goblet cells to agonist, baseline secretion may be the more important
mode of mucin release over the long term. With the simplifying assumptions that baseline se-
cretion is constant and that the mucins secreted by agonist exposure are limited to one bolus
release per day by a limited goblet cell synthetic capacity (Fig 2), baseline mucins exceeds those
released acutely by several fold (Fig 1B). An interesting feature of baseline mucin secretion is
that it appears to be sensitive to, and is possibly dependent upon, mechanical stresses (Figs 3–5
and 8–11). Further, with HBECCs the mechanical stresses of handling yielded what appeared
to be unitary baseline mucin secretory responses (Figs 3 and 4), possibly indicating a funda-
mental control mechanism. Thus, our view of the airway goblet cell phenotype may require a
substantial readjustment, for the data suggest that one of their primary functions is the produc-
tion and release of mucins at baseline.
In principal, a goblet cell, or a club cell at steady-state can secrete mucins at the same rate as
they are synthesized, fully independent of mucins sequestered in a storage pool. Hence, their
baseline secretory activity may be critical and their mucin stores, when present, considered a
reserve held for acute release. These notions are supported by our recent observations in adult
mouse airways, [i] that club cells secrete Muc5b at baseline even though mucin stores under
control conditions are not apparent by AB/APS staining [7,47], and [ii] that continuous mucus
production is required for airway defense in the mouse [48].
Potential pathways for baseline mucin secretion
In airway goblet cells, the purinergically stimulated, Ca2+-dependent exocytosis of mucin gran-
ules occurs via the classical, regulated secretory pathway [5,49,50]. In other secretory cells,
however, there is also a less well-known branch of the regulated secretory pathway, the ‘basal’
or ‘constitutive-like’ secretory pathway. It is suggested by studies demonstrating that cargo typ-
ically processed via the regulated secretory pathway is released exocytically from non-stimulat-
ed cells [5,51–53]. Interestingly,90% of von Willebrand factor, a similarly large glycoprotein
with strong homologies to polymeric mucins [54], is secreted from the vascular endothelium,
not by the exocytic release of Weibel-Palade bodies, but by the basal secretory pathway [17].
Hence, there is a good chance that a basal secretory pathway in goblet cells mediates baseline
mucin release either in part, or its entirety.
The final steps of regulated exocytosis consists of a sequence of highly specific protein-pro-
tein interactions beginning with Rab3/27 and Munc13 mediated tethering of a vesicle or gran-
ule to Munc18 or other SM protein defining an exocytic docking site, followed by assembly of
the SNARE complex, and ending with synaptotagmin/Ca2+-stimulated exocytic fusion and
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cargo release [55,56]. Each of the regulatory and SNARE proteins in the chain represents a
family with multiple isoforms. Data from genetically modified mice have generally indicated
the participation of at least two isoforms of each exocytic protein family in secretion. For in-
stance, knockout of Munc13-2 causes mucins to accumulate in club cells in the mouse airways,
suggesting a defect in baseline secretion, but agonist-stimulated secretion is unaffected [7].
Similarly, knockout of the Rab27 effector protein Slp2-a [57], or of Syt2 [58], affects either
baseline or agonist-stimulated mucin secretion, but not both. Knockout of VAMP8 strongly in-
hibits agonist-stimulated mucin secretion [59] and mucins accumulate at baseline; however the
baseline accumulation phenotype is distinctly less than that observed in Munc13-2 null mice
on the same genetic background (Y Zhu and CWDavis, unpublished observations). Impor-
tantly, none of the airway mucin secretory phenotypes in the mouse knockout models observed
to date resulted in a complete failure of mucin secretion. The results therefore suggest compli-
cated scenarios, e.g., independent SNARE pathways for baseline and agonist-stimulated mucin
secretion, a single SNARE pathway regulated differentially for baseline and agonist-induced se-
cretion, or a pathway(s) endowed with high degree of redundancy.
Shear stress-dependence of baseline secretion
Mucin secretion at baseline in vivo occurs in a mechanically dynamic lung environment: goblet
cells are exposed continuously to mechanical forces that may stimulate and/or influence the
production and secretion of mucins. These forces include shear stresses from air drag during
tidal breathing and cough, compressive stresses due to chest cavity pumping, and there may be
stresses arising from neighboring ciliated cells which are obviously very dynamic. Such me-
chanical forces have many, diverse effects on the lung at the cellular level [60], and recently
they have been shown to have profound effects on the regulation of the airway surface liquid
by stimulating the release of ATP into the lumen [38,61,62]. In this paper we show that baseline
mucin secretion from both native mouse trachea and HBECCs is not only highly sensitive to
the shear stresses associated with luminal perfusion, but may also be dependent on shear
stresses and/or other mechanical stimuli. In HBECCs subjected first to a Careful Wash proce-
dure to remove accumulated mucus, regular, periodic sampling lead to an seemingly stable
baseline rate of mucin secretion; yet, when the middle sampling period was lengthened from 1
to 72 h, the apparent rate of mucin secretion was significantly depressed (Fig 3B), suggesting
that the secretion observed was induced by the mechanical stimulation associated with the
sampling procedure. This possibility was confirmed by the subsequent finding that mucin re-
lease relaxes exponentially following a luminal wash, with a half-time of approximately 2.75 h
(Fig 4). Significantly, mucin secretion declined to near zero rates in the experiments of Fig 4,
suggesting that mechanical stresses may be essential in the lung for stimulating baseline mucin
production and secretion.
The stopped-flow perfusion experiments with mouse trachea generally supported the notion
of shear stress-induced baseline mucin release: the rates of release following restoration of per-
fusion were ~6-fold above those measured during stopped-flow (Fig 8C). Mucin release during
stopped-flow was determined as the mucins secreted above the perfused-baseline rate, but in
light of the immediacy of the mucin secretory response to jumps in flow rate for HBECCs (Fig
5A) there is a possibility that some of the supra-baseline release of mouse mucins immediately
following restoration of tracheal perfusion was in fact due to a similar response to shear-stress.
In other studies with HBECCs and airway cell lines, the onset of shear causes a spiking release
of ATP that is Ca2+-dependent, with a Cai
2+ signal that has similar time course [36,38,63]. In
fact, the time courses of both ATP release and intracellular Ca2+, are very much like the mucin
secretory response we observed with HBECCs (Fig 5A). Given the Ca2+-dependence of mucin
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secretion [49], it is therefore likely that the mucin secretory response of HBE goblet cells to
shear stress is triggered by Ca2+, and it is possible, though not necessary, that it is mediated by
ATP. Although HBE cells secrete ATP in response to shear stress, in fact, the concentrations of
ATP measured within the periciliary environment of HBECCs following the phasic shear
stresses<100 mdyn/cm2 were ~30 nM, or less [38], well below levels known to stimulate IP3
production, Ca2+ mobilization, or mucin secretion [9,64]. The shear stress-induced mucin se-
cretory response of P2Y2R null mice was intact (Fig 11), which supports the notion of a signal-
ing system independent of P2Y2R. This result is not conclusive, however, as mice with mucous
metaplasia are responsive to adenosine, via the A3 receptor [65]. Were the shear stress to cause
the release of ATP, its resulting ecto-metabolism to adenosine could have been stimulatory. In
any case, the sensor of shear stresses for goblet cells is unknown and the possibilities include
goblet cell mechanosensitive channels or receptors, autocrine factors, and paracrine factors
from ciliated cells.
Store-dependence of mucin secretion
One of the more interesting observations of these studies was the apparent positive relationship
between mucin store volume and levels of baseline and agonist-induced mucin secretion. In
mice with ovalbumin-induced mucous metaplasia, both stopped-flow and perfused baseline
mucin secretion rates were elevated (Fig 9), and a graded-dosing with IL-13 caused proportion-
al increases in club cell mucin stores and the rates of baseline and agonist-induced mucin secre-
tion (Fig 10). Similarly, in HBECCs treated with SMM, total mucin production and the rates of
baseline and agonist-induced mucin secretion were all increased (Fig 7). It is tempting to think
of this positive relationship in thermodynamic terms, i.e., as though the rate of mucin secretion
were higher because of a stronger driving force from the increase in mucin stores. Mucin secre-
tion, however, is not a dissipative process. Rather, the secretory pathway is highly energy de-
pendent, with each step of the process, including mucin transcription, translation, vesicle
transport, post-translational processing, packaging, and secretion, all being dependent on ATP
hydrolysis. Additionally, each step is tightly regulated. Hence, the positive relationship that ap-
pears to exist between the quantity of mucin stores and rate of mucin secretion implies the exis-
tence of a tight, negative feedback relationship between mucin stores and secretion, complete
with suitable sensors and signaling pathways—all of which remain to be identified.
In all of the common inflammatory airways diseases inflammation drives an increase in
mucin production and secretion. Much effort has gone into understanding the role of mucin
gene transcription in this process [46,66,67], but too little attention has been paid to the regula-
tion of mucin biosynthesis downstream of transcription or to the attendant changes that are
likely to occur in the secretory pathway, such as an expansion of the ER and Golgi compart-
ments. These aspects of mucin synthesis are important in their own right, but with realization
of the importance of baseline secretion and its dependence on mucin store volume, under-
standing the interrelationships and their regulation takes on an added urgency. These ques-
tions, as well as many others pertaining to the quantitative and regulatory relationships along
the mucin biosynthetic pathway and its secretion require a directed effort to elevate our knowl-
edge, to drive the development of pharmaceutic interventions that might benefit patients suf-
fering from obstructive airways diseases.
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S1 Fig. Perfusion plug and gasket with perfusion slot for Transwell.HBECCs grown in
TClears were perfused using a Neoprene gasket (2 mm thick) with an oval cutout to from a per-
fusion slot. The gasket was pressed down onto the luminal surface of the HBECC and held in
place with a ‘perfusion plug’, which possessed inflow and outflow channels and an O-ring seal,
as depicted.
(PDF)
S2 Fig. Severe mucous plugging in WTmice treated rigorously with IL-13.Mice received
Treatment #4 from Table 1: IL-13 (1 μg) was instilled into tracheas of isoflurane-anesethesized
mice on Days 0, 1, and 2, and the mice were euthanized for tissue harvest on Day 5. These im-
ages typify bronchial airways that are severely plugged, some, as in A, for considerable lengths.
Others, however, have open lumens, as in C. NOTE: Before euthanasia, the mice with this most
rigorous IL-13 treatment used, were apparently normal in all respects, despite the high degree
of mucous plugging. Possible reasons for the apparent good health include the lack of infection
and the fact that the mucus plugs were newly formed.
(PDF)
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